Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

3D Holographic Guidance, Navigation, and Control (3D GN&C) for Endovascular Aortic Repair (EVAR)

NCT06008613 is registered in ClinicalTrials.gov with The Cleveland Clinic as lead sponsor.

NCT NCT06008613
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06008613 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
3D Holographic Guidance, Navigation, and Control (3D GN&C) for Endovascular Aortic Repair (EVAR)
Lead sponsor
The Cleveland Clinic
Phase
Not applicable
Overall status
Completed
Start date
October 18, 2023
Completion date
June 19, 2025
Enrollment
2 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

abdominal aortic aneurysm